Form 4 Tracker
Grace Therapeutics, Inc.
GRCE

17 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 16, 2026Oct 17 12:42 AMOpaleye Management Inc.10% Owner
Purchase
36,347$1.89$68.8K2,944,354(I)

View →

Oct 15, 2026Oct 17 12:42 AMOpaleye Management Inc.10% Owner
Purchase
23,485$1.95$45.7K2,908,007(I)

View →

Oct 14, 2026Oct 17 12:42 AMOpaleye Management Inc.10% Owner
Purchase
11,233$1.93$21.7K2,884,522(I)

View →

Oct 12, 2026Oct 13 9:45 PMOpaleye Management Inc.10% Owner
Purchase
7,215$2.02$14.6K2,873,289(I)

View →

Oct 9, 2026Oct 13 9:45 PMOpaleye Management Inc.10% Owner
Purchase
5,340$2.04$10.9K2,866,074(I)

View →

Oct 8, 2026Oct 13 9:45 PMOpaleye Management Inc.10% Owner
Purchase
2,077$2.02$4.2K2,860,734(I)

View →

Oct 5, 2026Oct 5 10:46 PMOpaleye Management Inc.10% Owner
Purchase
1,694$2.06$3.5K2,858,657(I)

View →

Oct 2, 2026Oct 5 10:46 PMOpaleye Management Inc.10% Owner
Purchase
20,000$2.07$41.4K2,856,963(I)

View →

Oct 1, 2026Oct 5 10:46 PMOpaleye Management Inc.10% Owner
Purchase
38,796$2.04$79.0K2,836,963(I)

View →

Sep 29, 2026Oct 1 8:30 PMOpaleye Management Inc.10% Owner
Purchase
7,849$2.09$16.4K2,798,167(I)

View →

Sep 23, 2026Oct 1 8:05 PMOpaleye Management Inc.10% Owner
Purchase
5,318$2.10$11.2K2,790,318(I)

View →

Sep 21, 2026Oct 1 8:05 PMOpaleye Management Inc.10% Owner
Purchase
9,771$2.10$20.5K2,785,000(I)

View →

Sep 23, 2026Sep 23 10:19 PMOpaleye Management Inc.10% Owner
Purchase
5,318$2.10$11.2K2,855,318(I)

View →

Sep 21, 2026Sep 23 10:19 PMOpaleye Management Inc.10% Owner
Purchase
9,771$2.10$20.5K2,850,000(I)

View →

Sep 9, 2026Sep 10 8:05 PMOpaleye Management Inc.10% Owner
Purchase
5,836$2.09$12.2K2,775,229(I)

View →

Sep 8, 2026Sep 10 8:05 PMOpaleye Management Inc.10% Owner
Purchase
9,393$2.10$19.7K2,769,393(I)

View →

Sep 9, 2026Sep 10 11:30 AMPrashant KohliDirector, Chief Executive Officer
Purchase
100,000$2.14$214.0K121,357(D)

View →

Aug 14, 2026Aug 19 11:44 AMOpaleye Management Inc.10% Owner
Purchase
11,608$2.09$24.2K2,760,000(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 17, 2026Sep 21 8:22 PMEdward NeugeborenDirector
Grant/Award
12,200$2.1312,200(D)

View →

Sep 17, 2026Sep 21 8:20 PMBrian A DavisDirector
Grant/Award
—$2.1312,200(D)

View →

Sep 17, 2026Sep 21 8:15 PMVimal KavuruDirector
Grant/Award
12,200$2.1312,200(D)

View →

Sep 17, 2026Sep 21 8:13 PMGeorge KottayilDirector
Grant/Award
12,200$2.1312,200(D)

View →

Aug 28, 2026Sep 1 8:05 PMAmresh KumarVP Program Management
Grant/Award
35,760$2.1235,760(D)

View →

Aug 28, 2026Sep 1 8:05 PMPrashant KohliDirector, Chief Executive Officer
Grant/Award
267,160$2.12267,160(D)

View →

Aug 28, 2026Sep 1 8:05 PMLoch R. MacdonaldChief Medical Officer
Grant/Award
54,690$2.1254,690(D)

View →

Aug 28, 2026Sep 1 8:05 PMRobert J DelaversanoPrincipal Financial Officer
Grant/Award
33,660$2.1233,660(D)

View →